Gene Synthesis Market to 2025 - Global Analysis and Forecasts By Products & Services (Services, Consumable, Software), Application (Research & Development Activities, Diagnostics, Therapeutics, Others) End Users (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, Others) and Geography

Publication Month: Aug 2018 | Report Code: TIPHE100001214 | No. of Pages: 150 | Category: Biotechnology | Status: Published

UPDATE AVAILABLE ON-DEMAND
Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Gene synthesis in healthcare market was valued at US$ 3,991.23 million in 2017 and it is projected to reach US$ 107,797.82 million by 2025; it is expected to grow at a CAGR of 28.7% from 2017 to 2025.

 

This research report provides insights on the global gene synthesis market. Gene synthesis is a technique of synthetic biology which is used to create artificial genes in the laboratory. The method works based on solid-phase DNA synthesis, it differs from molecular cloning and polymerase chain reaction (PCR). Gene synthesis is used for molecular cloning, creating fusion proteins, or achieving sufficiently high protein expression levels. Compared to traditional molecular cloning techniques, the gene synthesis service is helpful in saving both time and money while offering unparalleled top to bottom customizability. Factors driving this market are increase in investments & funds for gene synthesis, rising numbers of start-up companies and technological advancements are key drivers for the growth of the market. However, factors such as lack of skilled professionals and long approval processes are likely to restrain the market growth to a certain extent.

 

The Gene synthesis in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

 

Lucrative Regions for Gene synthesis in Healthcare Market

Lucrative Regions for Gene synthesis in Healthcare Market

Get more information on this report :


 

Market Insights


Growing Applications of Gene synthesis in Healthcare to Drive Gene synthesis in Healthcare Market Growth

Gene synthesis is mostly accepted tool in fields of recombinant DNA technology, which includes recombinant protein production. For instance, in July 2018, Innovate UK, the UK’s innovation agency, funded approximately US$ 1.76 million (£1.3 million) project, Evonetix Ltd, (UK) that will be in partnership with Durham University. The funds will be used for the development of a new enzymatic approach to DNA synthesis. Moreover, in April 2018, DNA Script received approximately US$5.5 million in grant funds from the European Commission and Bpifrance (French investment bank). The technology platform, and other related resources are helping the company to accelerate the development of the gene synthesis. Companies have also increased their research and development funds for the enhancement of the gene synthesis. Additionally, in 2016, Twist Bioscience raised its revenue with US$ 61 million for the scale-up and commercial operation of the silicon chip-based high throughput low-cost gene synthesis platform. 

Globally, the gene synthesis has set benchmark with its innovations and the dynamic results. The industry has attracted various global leaders to invest for gene synthesis. For instance, in November 2017, Bolt Threads raised US$123 million in Series D funding that was led by Ballie Gifford along with the others such as, aforementioned Formation 8, Founders Fund, Fidelity Management, Research Company and Temasek. Allen & Company LLC. Bolt Threads also announced in TechCrunch that it has added to the amount for Series D round to sum up the amount of US$213 million. Additionally, in 2015, Zymergen received US$44 million funds from investors such as Transcript, AME Cloud Ventures, Data Collective, Draper Fisher Jurvetson, HVF, Innovation Endeavors, Obvious ventures, True Ventures and Two Sigma Ventures. 

The following table represents the investments made in various countries for the biotechnology development.

In March 2018, SynbiCITE (UK) received around US$ 17.6 million (£13M) grants and US$ 318.5 million (£234M) private investment. Importantly, SynbiCITE is made for increasing synbio applications in the UK. The SynbiCITE has supported the synbio at national level for the increase of gene synthesis applications. Thus, a huge investments made by the government, companies is expected to increase the growth of the global gene synthesis market over the forecast years.

Increasing number of new entrants conducting gene synthesis procedures is one of the major factor driving the growth of the global gene synthesis market. The start-ups are proliferating due to support from accelerators to promote and commercially exploit the biological and engineering applications. The supportive government of respective geographies facilitating adequate funds for research and developments in the biotechnology sectors are helpful for the start-up companies to seek basic investments for setting up a new venture. For instance, the first synthetic biology accelerator is Indie Bio (California, US) and EU (Ireland). Moreover, in December 2017, Molecular Assemblies, (San Diego, US) develops a latest enzymatic method for DNA synthesis, has raised US$2.3 million. In addition, DNA Script (France), founded in 2014 led by Illumina Ventures and Merck Ventures and other investors Sofinnova Partners, Kurma Partners, and Idinvest Partners, raised more than US$ 12 million (€11M). These funds and the support of major players in the field helps the company to make the unique DNA synthesis technology for industrial scale-up.

Asia Pacific also witnesses increase in the number of start-up companies as the governments in Asian countries are providing funds for the development in bioengineering procedures such as gene synthesis. For instance, in May 2018, Indian government funded IITM Bioincubator, to the department of Indian Institute of Technology Madras as a state-ofart research facility in cancer biology and for setting up of a bioinformatics infrastructure facility. The funds were provided by various agencies such as, CSIR, DAE, DBT, and DST and others. Similarly, in China, Chinaccelerator is a financer that provides mentorship programs by helping start-ups. It helps in the establishments of starts-ups by assisting the companies with venture capitals under programs such as RebelBio, and Indie Bio. Availability of funds for the innovative concepts in advanced biotechnological approach motivates entrepreneurs across the globe to establish new companies and service provision for gene synthesis. Thus, the aforementioned factors are likely to support the market growth over the forecast period.

 

Product and Services-Based Insights

The services segment held the major market share among the products & services segments. In 2017, the services segment held a largest market share of 51.1% of the gene synthesis market, by products & services. This segment is also expected to dominate the market in 2025 owing to analysis and data management solutions, service partnerships and financial solutions. Furthermore, the services segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

 

Gene synthesis in Healthcare Market, by Product and Services – 2017 and 2025

Gene synthesis in Healthcare Market, by Product and Services – 2017 and 2025

Get more information on this report :


 

Application-Based Insights

The research & developmental activities segment is expected to dominate the market based on application. Research & developmental activities segment is anticipated to grow at a CAGR of 30.9% during the forecast period. The R&D helps to build variant libraries, genes, operons, increase the function of proteins, and to test the particular gene is expected to boost the demand for breast implants in the coming years.

 

End User-Based Insights

The academic & research institutes segment is likely to dominate the market, by end user. In 2017, the academic & research institutes segment held a largest market share of 45.5% of the gene synthesis market, by technology. This segment is also expected to dominate the market in 2025. However, the biotechnology & pharmaceutical companies segment is anticipated to witness the fastest growth rate of 30.1% during the forecast period, 2018 to 2025. This higher growth rate of the segment owing to the increasing government funding and partnerships between the various organizations in all the regions


Strategic Insights

The Gene synthesis in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

 

Gene synthesis in Healthcare Market – by Product and Services

  • Software
  • Consumables
  • Services

Gene synthesis in Healthcare Market – by Application

  • Research & Development Activities
  •  Diagnostics
  •  Therapeutics
  •  Others

Gene synthesis in Healthcare Market – by End User

  • Academic and Research Institutes
  • Pharma & Biotech Companies
  • Diagnostic Laboratories
  • Others

Gene synthesis in Healthcare Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

 

Company Profiles

  • Eurofins Scientific
  • Thermo Fisher Scientific Inc.
  • GenScript
  • BIONEER CORPORATION
  • Integrated DNA Technologies
  • ATUM
  • Twist Bioscience
  • BioCat GmbH
  • OriGene Technologies, Inc.
  • GENEWIZ.
TABLE OF CONTENTS

1. INTRODUCTION 20
1.1 SCOPE OF THE STUDY 20
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 20

2. GLOBAL GENE SYNTHESIS MARKET - KEY TAKEAWAYS 21

3. GLOBAL GENE SYNTHESIS MARKET - MARKET LANDSCAPE 24
3.1 OVERVIEW 24
3.2 MARKET SEGMENTATION 24
3.2.1 Global Gene Synthesis Market - By Products & Services 25
3.2.2 Global Gene Synthesis Market - By Application 25
3.2.3 Global Gene Synthesis Market - By End User 26
3.2.4 Global Gene Synthesis Market - By Geography 26
3.3 PEST ANALYSIS 27
3.3.1 North America - PEST Analysis 27
3.3.2 Europe- PEST Analysis 29
3.3.3 Asia Pacific - PEST Analysis 31
3.3.4 Middle East And Africa- PEST Analysis 33
3.3.5 South and Central America - PEST Analysis 35

4. GLOBAL GENE SYNTHESIS MARKET - KEY MARKET DYNAMICS 37
4.1 KEY MARKET DRIVERS 37
4.1.1 Increase in Investments & Funds for Gene Synthesis 37
4.1.2 Rising Numbers of Start-up Companies 38
4.1.3 Technological Advancements 39
4.2 KEY MARKET RESTRAINTS 40
4.2.1 Lack of Skilled Professionals 40
4.2.2 Long Approval Processes 40
4.3 KEY MARKET OPPORTUNITIES 41
4.3.1 Emerging Nations 41
4.4 FUTURE TRENDS 42
4.4.1 Usage of Gene Synthesis in Personalized Medicine 42
4.5 IMPACT ANALYSIS 43

5. GENE SYNTHESIS MARKET - GLOBAL ANALYSIS 44
5.1 GLOBAL GENE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS 44
5.2 GLOBAL GENE SYNTHESIS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 45
5.3 MARKET POSITIONING 46
5.4 PERFORMANCE OF KEY PLAYERS 46
5.4.1 Eurofins Scientific 46
5.4.2 GenScript 46
5.4.3 Thermo Fisher Scientific Inc. 46
5.5 EXPERT OPINIONS 47

6. GENE SYNTHESIS MARKET ANALYSIS- BY PRODUCTS & SERVICES 48
6.1 OVERVIEW 48
6.2 GLOBAL GENE SYNTHESIS MARKET SHARE, BY PRODUCTS & SERVICES, 2017 & 2025 (%) 48
6.3 CONSUMABLES 49
6.3.1 Overview 49
6.3.2 Global Consumables Market Revenue and Forecasts to 2025 (US$ Mn) 50
6.4 SOFTWARE 50
6.4.1 Overview 50
6.4.2 Global Software Market Revenue and Forecasts to 2025 (US$ Mn) 51
6.5 SERVICES MARKET 51
6.5.1 Overview 51
6.5.2 Global Services Market Revenue and Forecasts to 2025 (US$ Mn) 52

7. GLOBAL GENE SYNTHESIS MARKET ANALYSIS- BY APPLICATION 53
7.1 OVERVIEW 53
7.2 GLOBAL GENE SYNTHESIS MARKET SHARE, BY APPLICATION, 2017 & 2025 (%) 53
7.3 DIAGNOSTICS 54
7.3.1 Overview 54
7.3.2 Global Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn) 54
7.4 THERAPEUTICS 55
7.4.1 Overview 55
7.4.2 Global Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 55
7.5 RESEARCH & DEVELOPMENTAL ACTIVITIES 56
7.5.1 Overview 56
7.5.2 Global Research & Developmental Activities Market Revenue and Forecasts to 2025 (US$ Mn) 56
7.6 OTHER APPLICATIONS 57
7.6.1 Overview 57
7.6.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 57

8. GLOBAL GENE SYNTHESIS MARKET ANALYSIS - BY END USER 58
8.1 OVERVIEW 58
8.2 GLOBAL GENE SYNTHESIS MARKET SHARE, BY END USER, 2017 & 2025 (%) 58
8.3 ACADEMIC & RESEARCH INSTITUTES MARKET 59
8.3.1 Overview 59
8.3.2 Global Academic & Research Institutes Market Revenue and Forecasts to 2025 (US$ Mn) 59
8.4 DIAGNOSTIC LABORATORIES MARKET 60
8.4.1 Overview 60
8.4.2 Global Diagnostic Laboratories Market Revenue and Forecasts to 2025 (US$ Mn) 60
8.5 BIOTECH & PHARMACEUTICAL COMPANIES MARKET 61
8.5.1 Overview 61
8.5.2 Global Biotech & Pharmaceutical Companies Market Revenue and Forecasts to 2025 (US$ Mn) 61
8.6 OTHERS MARKET 62
8.6.1 Overview 62
8.6.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 62

9. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 63
9.1 OVERVIEW 63
9.2 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
9.3 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 64
9.4 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 65
9.5 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 65
9.6 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 66
9.7 US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
9.7.1 US Gene synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 68
9.7.2 US Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 68
9.7.3 US Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 69
9.7.4 US Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 69
9.8 CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.8.1 Canada Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 70
9.8.2 Canada Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 71
9.8.3 Canada Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 71
9.8.4 Canada Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 71
9.9 MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
9.9.1 Mexico Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 72
9.9.2 Mexico Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 73
9.9.3 Mexico Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 73
9.9.4 Mexico Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 73

10. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 74
10.1 OVERVIEW 74
10.2 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
10.3 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 75
10.4 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
10.5 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 76
10.6 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 77
10.7 UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
10.7.1 UK Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 79
10.7.2 UK Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 79
10.7.3 UK Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 80
10.7.4 UK Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 80
10.8 GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
10.8.1 Germany Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 81
10.8.2 Germany Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 82
10.8.3 Germany Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 82
10.8.4 Germany Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 82
10.9 FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
10.9.1 France Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 83
10.9.2 France Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 84
10.9.3 France Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84
10.9.4 France Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 84

11. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 85
11.1 OVERVIEW 85
11.2 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
11.3 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 86
11.4 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 87
11.5 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 87
11.6 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 88
11.7 CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
11.7.1 China Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 89
11.7.2 China Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 90
11.7.3 China Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 90
11.7.4 China Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 90
11.8 JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
11.8.1 Japan Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 91
11.8.2 Japan Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 92
11.8.3 Japan Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 92
11.8.4 Japan Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 92
11.9 INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93
11.9.1 India Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 93
11.9.2 India Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 94
11.9.3 India Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 94
11.9.4 India Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 94

12. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 95
12.1 OVERVIEW 95
12.2 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
12.3 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 96
12.4 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
12.5 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
12.6 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 98
12.7 UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
12.8 UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
12.8.1 UAE Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 100
12.8.2 UAE Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 100
12.8.3 UAE Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 100
12.9 SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
12.10 SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
12.10.1 Saudi Arabia Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 102
12.10.2 Saudi Arabia Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 102
12.10.3 Saudi Arabia Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 102
12.11 SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
12.12 SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
12.12.1 South Africa Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 104
12.12.2 South Africa Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104
12.12.3 South Africa Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 104

13. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 105
13.1 OVERVIEW 105
13.2 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106
13.3 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 106
13.4 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107
13.5 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107
13.6 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 108
13.7 BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 109
13.7.1 Brazil Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 109
13.7.2 Brazil Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 110
13.7.3 Brazil Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 110
13.7.4 Brazil Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 110

14. GENE SYNTHESIS MARKET -INDUSTRY LANDSCAPE 111
14.1 OVERVIEW 111
14.2 GROWTH STRATEGIES IN GENE SYNTHESIS MARKET, 2016-2018 111
14.3 ORGANIC GROWTH STRATEGIES 111
14.3.1 Overview 111
14.3.2 Product Launch 112
14.3.3 Expansion 113
14.3.4 Approvals 113
14.4 INORGANIC GROWTH STRATEGIES 114
14.4.1 Overview 114
14.4.2 Agreements 114
14.4.3 Acquisitions 115
14.4.4 Partnerships & Collaborations 116
14.4.5 Other Inorganic Strategies 117

15. GENE SYNTHESIS MARKET -KEY COMPANY PROFILES 118
15.1 THERMO FISHER SCIENTIFIC INC. 118
15.1.1 Key Facts 118
15.1.2 Business Description 118
15.1.3 Financial Overview 119
15.1.4 Product Portfolio 119
15.1.5 SWOT Analysis 120
15.1.6 Key Developments 120
15.2 INTEGRATED DNA TECHNOLOGIES, INC. 121
15.2.1 Key Facts 121
15.2.2 Business Description 121
15.2.3 Financial Overview 121
15.2.4 Product Portfolio 121
15.2.5 SWOT Analysis 122
15.2.6 Key Developments 122
15.3 TWIST BIOSCIENCE 123
15.3.1 Key Facts 123
15.3.2 Business Description 123
15.3.3 Financial Overview 123
15.3.4 Product portfolio 123
15.3.5 SWOT ANALYSIS 124
15.3.6 KEY DEVELOPMENTS 124
15.4 ORIGENE TECHNOLOGIES, INC. 126
15.4.1 Key Facts 126
15.4.2 Business Description 126
15.4.3 Financial Overview 126
15.4.4 Product Portfolio 126
15.4.5 SWOT Analysis 127
15.4.6 Key Developments 127
15.5 BIOCAT GMBH 128
15.5.1 Key Facts 128
15.5.2 Business Description 128
15.5.3 Financial Overview 129
15.5.4 Product Portfolio 129
15.5.5 SWOT Analysis 129
15.5.6 Key Developments 129
15.6 GENSCRIPT 130
15.6.1 Key Facts 130
15.6.2 Business Description 130
15.6.3 Financial Overview 131
15.6.4 Product Portfolio 131
15.6.5 SWOT Analysis 132
15.6.6 Key Developments 132
15.7 EUROFINS SCIENTIFIC 133
15.7.1 Key Facts 133
15.7.2 Business Description 133
15.7.3 Financial Overview 133
15.7.4 Product/ Services Portfolio 134
15.7.5 SWOT Analysis 134
15.7.6 Key Developments 134
15.8 BIONEER CORPORATION 136
15.8.1 Key Facts 136
15.8.2 Business Description 136
15.8.3 Financial Overview 136
15.8.4 Product/ Services Portfolio 137
15.8.5 SWOT Analysis 137
15.8.6 Key Developments 138
15.9 ATUM 139
15.9.1 Key Facts 139
15.9.2 Business Description 139
15.9.3 Financial Overview 140
15.9.4 Product Portfolio 140
15.9.5 SWOT Analysis 140
15.9.6 Key Developments 140
15.10 GENEWIZ 141
15.10.1 Key Facts 141
15.10.2 Business Description 141
15.10.3 Financial Overview 142
15.10.4 Service Portfolio 142
15.10.5 SWOT Analysis 142
15.10.6 Key Developments 143

16. APPENDIX 144
16.1 ABOUT THE INSIGHT PARTNERS 144
16.2 GLOSSARY OF TERMS 145
16.3 METHODOLOGY 147
16.3.1 Coverage 148
16.3.2 Secondary Research 149
16.3.3 Primary Research 149

LIST OF TABLES

TABLE 1. VENTURE CAPITAL FIRMS INVESTING IN SOME COUNTRIES FOR BIOTECHNOLOGY 37
TABLE 2. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 64
TABLE 3. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 65
TABLE 4. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 65
TABLE 5. US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 68
TABLE 6. US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
TABLE 7. US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69
TABLE 8. CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 71
TABLE 9. CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 71
TABLE 10. CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 71
TABLE 11. MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 73
TABLE 12. MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 73
TABLE 13. MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 73
TABLE 14. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 75
TABLE 15. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
TABLE 16. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 76
TABLE 17. UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 79
TABLE 18. UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 80
TABLE 19. UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 80
TABLE 20. GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 82
TABLE 21. GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 82
TABLE 22. GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 82
TABLE 23. FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 84
TABLE 24. FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
TABLE 25. FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 84
TABLE 26. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 86
TABLE 27. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 87
TABLE 28. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 87
TABLE 29. CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 90
TABLE 30. CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 90
TABLE 31. CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 90
TABLE 32. JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 92
TABLE 33. JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
TABLE 34. JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 92
TABLE 35. INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 94
TABLE 36. INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 94
TABLE 37. INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 94
TABLE 38. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 96
TABLE 39. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 40. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
TABLE 41. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 98
TABLE 42. UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 100
TABLE 43. UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
TABLE 44. UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 100
TABLE 45. SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 102
TABLE 46. SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 102
TABLE 47. SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 102
TABLE 48. SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 104
TABLE 49. SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
TABLE 50. SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 104
TABLE 51. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 106
TABLE 52. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107
TABLE 53. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107
TABLE 54. BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 110
TABLE 55. BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 110
TABLE 56. BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 110
TABLE 57. RECENT PRODUCT LAUNCH IN GENE SYNTHESIS MARKET 112
TABLE 58. RECENT EXPANSION IN GENE SYNTHESIS MARKET 113
TABLE 59. RECENT APPROVALS IN GENE SYNTHESIS MARKET 113
TABLE 60. RECENT AGREEMENTS IN GENE SYNTHESIS MARKET 114
TABLE 61. RECENT ACQUISITIONS IN GENE SYNTHESIS MARKET 115
TABLE 62. RECENT PARTNERSHIPS & COLLABORATIONS IN GENE SYNTHESIS MARKET 116
TABLE 63. RECENT OTHER INORGANIC STRATEGIES IN GENE SYNTHESIS MARKET 117
TABLE 64. GLOSSARY OF TERMS, GENE SYNTHESIS MARKET 145

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC GENE SYNTHESIS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 21
FIGURE 2. GLOBAL GENE SYNTHESIS MARKET BY PRODUCTS & SERVICES, MARKET SHARE (%), 2017 22
FIGURE 3. GLOBAL GENE SYNTHESIS MARKET BY APPLICATION, MARKET SHARE (%), 2017 22
FIGURE 4. GLOBAL GENE SYNTHESIS MARKET BY END USER, MARKET SHARE (%), 2017 23
FIGURE 5. GENE SYNTHESIS MARKET SEGMENTATION 24
FIGURE 6. GENE SYNTHESIS SEGMENTATION, BY REGION 25
FIGURE 7. NORTH AMERICA PEST ANALYSIS 27
FIGURE 8. EUROPE PEST ANALYSIS 29
FIGURE 9. ASIA PACIFIC PEST ANALYSIS 31
FIGURE 10. MIDDLE EAST AND AFRICA PEST ANALYSIS 33
FIGURE 11. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 35
FIGURE 12. GENE SYNTHESIS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 43
FIGURE 13. GLOBAL GENE SYNTHESIS MARKET - REVENUE FORECASTS AND ANALYSIS - 2016- 2025 44
FIGURE 14. GLOBAL GENE SYNTHESIS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 45
FIGURE 15. GLOBAL GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES, 2017 & 2025 (%) 48
FIGURE 16. GLOBAL CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 17. GLOBAL SOFTWARE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 18. GLOBAL SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 19. GLOBAL GENE SYNTHESIS MARKET SHARE, BY APPLICATION 2017 & 2025 (%) 53
FIGURE 20. GLOBAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 21. GLOBAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 22. GLOBAL RESEARCH & DEVELOPMENTAL ACTIVITIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 23. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 24. GLOBAL GENE SYNTHESIS MARKET SHARE, BY END USER, 2017 & 2025 (%) 58
FIGURE 25. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 26. GLOBAL DIAGNOSTIC LABORATORIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
FIGURE 27. GLOBAL BIOTECH & PHARMACEUTICAL COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 28. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
FIGURE 29. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 63
FIGURE 30. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
FIGURE 31. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 66
FIGURE 32. US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 33. CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 34. MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
FIGURE 35. EUROPE GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 74
FIGURE 36. EUROPE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
FIGURE 37. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 77
FIGURE 38. UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
FIGURE 39. GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
FIGURE 40. FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 41. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 85
FIGURE 42. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
FIGURE 43. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 88
FIGURE 44. CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
FIGURE 45. JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
FIGURE 46. INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93
FIGURE 47. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 95
FIGURE 48. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 49. UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
FIGURE 50. SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
FIGURE 51. SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
FIGURE 52. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 105
FIGURE 53. SOUTH AND CENTRAL AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106
FIGURE 54. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 108
FIGURE 55. BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 109
FIGURE 56. GROWTH STRATEGIES IN GENE SYNTHESISMARKET, 2016-2018 111
FIGURE 57. ORGANIC GROWTH STRATEGIES IN GENE SYNTHESIS MARKET, 2016-2018 112
FIGURE 58. INORGANIC GROWTH STRATEGIES IN GENE SYNTHESIS MARKET, 2016-2018 114
The List of Companies

1. Thermo Fisher Scientific Inc
2. Integrated DNA Technologies, Inc.
3. Twist Bioscience
4. OriGene Technologies, Inc.
5. BioCat GmbH
6. GenScript
7. Eurofins Scientific
8. Bioneer Corporation
9. ATUM
10. GENEWIZ
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the gene synthesis market.

- Highlights key business priorities in order to assist companies to realign their business strategies

- The key findings and recommendations highlight crucial progressive industry trends in the global gene synthesis market, thereby allowing players across the value chain to develop effective long-term strategies.

- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPHE100001214
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing